Kolelitiasis
Published on September 13, 2026
Risk Factors
Female sex, age > 40, obesity (), multiparity, rapid weight loss, oral contraceptive or estrogen therapy, Native American or Hispanic ethnicity, family history, ileal disease (Crohn), total parenteral nutrition, cystic fibrosis, cirrhosis, hemolytic anemias (sickle cell disease, hereditary spherocytosis)
Etiology
Cholesterol supersaturation of bile (most common), bilirubin overproduction (pigment stones), gallbladder hypomotility leading to bile stasis
Presentation
Often asymptomatic and found incidentally. When symptomatic: episodic right upper quadrant (RUQ) or epigastric pain after fatty meals ("biliary colic"), lasting 30 minutes to several hours, with nausea and vomiting
Classic Exam
RUQ tenderness during an acute episode. Between episodes, the exam is often normal. No peritoneal signs, no fever, negative Murphy sign (a positive Murphy sign suggests cholecystitis, not simple cholelithiasis)
Diagnostics
RUQ ultrasound: hyperechoic foci with posterior acoustic shadowing and stone mobility. Labs typically normal in uncomplicated disease
Management
Asymptomatic: observation (no surgery). Symptomatic biliary colic: elective laparoscopic cholecystectomy. Medical dissolution with ursodeoxycholic acid reserved for poor surgical candidates with small cholesterol stones
01Pathophysiology
Gallstones form when the chemical balance of bile within the gallbladder is disrupted. Bile is composed of cholesterol, bile salts, and phospholipids (mainly lecithin). Under normal conditions, bile salts and lecithin keep cholesterol solubilized in mixed micelles. When cholesterol concentration exceeds the solubilizing capacity of bile salts and lecithin, bile becomes supersaturated, and cholesterol crystals nucleate and grow into stones. This is the mechanism behind cholesterol stones, which account for roughly 80% of gallstones in Western populations.
The classic mnemonic "4 F's" (Fat, Female, Fertile, Forty) captures the key risk factors. Estrogen increases hepatic cholesterol secretion and reduces bile salt synthesis, explaining why women, especially those who are pregnant, taking oral contraceptives, or on hormone replacement therapy, are at higher risk. Obesity increases cholesterol synthesis and secretion into bile, while rapid weight loss (such as after bariatric surgery or very-low-calorie diets) paradoxically increases stone formation because the liver mobilizes cholesterol from peripheral stores faster than bile salts can solubilize it. Gallbladder hypomotility during fasting, prolonged total parenteral nutrition, or pregnancy also promotes stasis and stone formation.
Pigment stones account for the remaining 20% and come in two subtypes. Black pigment stones are composed of calcium bilirubinate and form in conditions of chronic hemolysis (sickle cell disease, hereditary spherocytosis, thalassemia) or cirrhosis, where unconjugated bilirubin is overproduced. These stones form within the gallbladder itself. Brown pigment stones are associated with biliary stasis and infection (particularly with E. coli and biliary parasites) and can form in the bile ducts (primary choledocholithiasis). They are more common in East Asian populations.
The link between pathophysiology and symptoms is direct: stones sitting quietly in the gallbladder cause no symptoms. Pain occurs only when a stone transiently obstructs the cystic duct during gallbladder contraction (stimulated by cholecystokinin release after a fatty meal). The gallbladder contracts against the obstruction, producing visceral pain felt in the epigastrium or RUQ. When the stone falls back into the gallbladder or passes through, the pain resolves. This is why biliary colic is episodic and self-limited (typically < 6 hours). If the stone becomes impacted and does not dislodge, this progresses to acute cholecystitis, a different and more serious diagnosis.
02Classification and Clinical Manifestation
Cholesterol stones
COMPOSITION
Cholesterol monohydrate crystals
ASSOCIATED CONDITIONS
Obesity, estrogen, rapid weight loss, Native American ethnicity, ileal disease
APPEARANCE
Yellow-green, often solitary or few, large
RADIOPACITY
Radiolucent (not seen on plain X-ray, ~80%)
Black pigment stones
COMPOSITION
Calcium bilirubinate polymer
ASSOCIATED CONDITIONS
Chronic hemolysis (sickle cell, spherocytosis), cirrhosis, cystic fibrosis
APPEARANCE
Small, black, multiple, hard
RADIOPACITY
Radiopaque (visible on X-ray)
Brown pigment stones
COMPOSITION
Calcium salts of unconjugated bilirubin + fatty acids
ASSOCIATED CONDITIONS
Biliary infection, parasites (Clonorchis, Ascaris), bile duct stasis
APPEARANCE
Soft, earthy brown, often in bile ducts
RADIOPACITY
Variable
STONE TYPE | COMPOSITION | ASSOCIATED CONDITIONS | APPEARANCE | RADIOPACITY |
|---|---|---|---|---|
Cholesterol stones | Cholesterol monohydrate crystals | Obesity, estrogen, rapid weight loss, Native American ethnicity, ileal disease | Yellow-green, often solitary or few, large | Radiolucent (not seen on plain X-ray, ~80%) |
Black pigment stones | Calcium bilirubinate polymer | Chronic hemolysis (sickle cell, spherocytosis), cirrhosis, cystic fibrosis | Small, black, multiple, hard | Radiopaque (visible on X-ray) |
Brown pigment stones | Calcium salts of unconjugated bilirubin + fatty acids | Biliary infection, parasites (Clonorchis, Ascaris), bile duct stasis | Soft, earthy brown, often in bile ducts | Variable |
Asymptomatic cholelithiasis
PRESENTATION
Incidental finding on imaging
KEY FEATURES
No pain, normal labs. Present in 80% of patients with gallstones. Does NOT require treatment
Biliary colic (symptomatic cholelithiasis)
PRESENTATION
Episodic RUQ or epigastric pain, nausea, vomiting, triggered by fatty meals
KEY FEATURES
Pain lasts 30 min to 6 hours, then resolves completely. No fever, no leukocytosis, negative Murphy sign. Labs normal
Complicated gallstone disease
PRESENTATION
Progression to cholecystitis, choledocholithiasis, cholangitis, gallstone pancreatitis, gallstone ileus
KEY FEATURES
Persistent pain (> 6 hours), fever, jaundice, elevated WBC, abnormal liver enzymes or lipase. These are distinct diagnoses requiring different management
CLINICAL CATEGORY | PRESENTATION | KEY FEATURES |
|---|---|---|
Asymptomatic cholelithiasis | Incidental finding on imaging | No pain, normal labs. Present in 80% of patients with gallstones. Does NOT require treatment |
Biliary colic (symptomatic cholelithiasis) | Episodic RUQ or epigastric pain, nausea, vomiting, triggered by fatty meals | Pain lasts 30 min to 6 hours, then resolves completely. No fever, no leukocytosis, negative Murphy sign. Labs normal |
Complicated gallstone disease | Progression to cholecystitis, choledocholithiasis, cholangitis, gallstone pancreatitis, gallstone ileus | Persistent pain (> 6 hours), fever, jaundice, elevated WBC, abnormal liver enzymes or lipase. These are distinct diagnoses requiring different management |
03Diagnostic Workup
RUQ ultrasound
ROLE
Best initial test and most accurate test for gallstones
EXPECTED FINDINGS
Hyperechoic foci with posterior acoustic shadowing, stone mobility with position change. Thin gallbladder wall (< 3 mm), no pericholecystic fluid in uncomplicated disease
Complete blood count (CBC)
ROLE
Rule out complications
EXPECTED FINDINGS
Normal WBC in simple cholelithiasis. Leukocytosis suggests cholecystitis
Liver function tests (LFTs)
ROLE
Rule out choledocholithiasis
EXPECTED FINDINGS
Normal AST, ALT, alkaline phosphatase, and bilirubin in uncomplicated cholelithiasis. Elevations suggest common bile duct involvement
Lipase / Amylase
ROLE
Rule out gallstone pancreatitis
EXPECTED FINDINGS
Normal in cholelithiasis alone. Elevated lipase (> 3x upper limit of normal) points toward pancreatitis
Abdominal X-ray (KUB)
ROLE
Low sensitivity, not recommended as primary test
EXPECTED FINDINGS
Only ~15-20% of gallstones are radiopaque (pigment stones). Not useful for diagnosis
HIDA scan (hepatobiliary iminodiacetic acid scan)
ROLE
Used when cholecystitis is suspected but ultrasound is equivocal
EXPECTED FINDINGS
Not indicated for simple cholelithiasis. Shows non-visualization of gallbladder in cholecystitis (cystic duct obstruction)
MRCP (magnetic resonance cholangiopancreatography)
ROLE
Evaluate for suspected choledocholithiasis
EXPECTED FINDINGS
Used when LFTs are abnormal or common bile duct is dilated on ultrasound
TEST | ROLE | EXPECTED FINDINGS |
|---|---|---|
RUQ ultrasound | Best initial test and most accurate test for gallstones | Hyperechoic foci with posterior acoustic shadowing, stone mobility with position change. Thin gallbladder wall (< 3 mm), no pericholecystic fluid in uncomplicated disease |
Complete blood count (CBC) | Rule out complications | Normal WBC in simple cholelithiasis. Leukocytosis suggests cholecystitis |
Liver function tests (LFTs) | Rule out choledocholithiasis | Normal AST, ALT, alkaline phosphatase, and bilirubin in uncomplicated cholelithiasis. Elevations suggest common bile duct involvement |
Lipase / Amylase | Rule out gallstone pancreatitis | Normal in cholelithiasis alone. Elevated lipase (> 3x upper limit of normal) points toward pancreatitis |
Abdominal X-ray (KUB) | Low sensitivity, not recommended as primary test | Only ~15-20% of gallstones are radiopaque (pigment stones). Not useful for diagnosis |
HIDA scan (hepatobiliary iminodiacetic acid scan) | Used when cholecystitis is suspected but ultrasound is equivocal | Not indicated for simple cholelithiasis. Shows non-visualization of gallbladder in cholecystitis (cystic duct obstruction) |
MRCP (magnetic resonance cholangiopancreatography) | Evaluate for suspected choledocholithiasis | Used when LFTs are abnormal or common bile duct is dilated on ultrasound |
The best initial test for cholelithiasis is a right upper quadrant ultrasound. It is also the most accurate test for detecting stones within the gallbladder, with a sensitivity above 95%. The hallmark finding is a hyperechoic focus that casts a posterior acoustic shadow and moves with changes in patient position (demonstrating mobility and distinguishing stones from polyps, which are fixed to the wall). Ultrasound also allows assessment of gallbladder wall thickness, pericholecystic fluid, and common bile duct diameter, which helps determine whether complications are present.
In uncomplicated cholelithiasis, laboratory tests are expected to be entirely normal. The reason you still order a CBC, liver function panel, and lipase is not to diagnose gallstones but to rule out complications. A normal WBC argues against cholecystitis. Normal bilirubin and alkaline phosphatase argue against a stone in the common bile duct (choledocholithiasis). Normal lipase rules out gallstone pancreatitis. On the exam, when a vignette gives you a patient with biliary colic and completely normal labs, they are confirming uncomplicated cholelithiasis and guiding you toward elective management.
Plain abdominal X-ray is a poor test for gallstones because the majority (cholesterol stones) are radiolucent. Do not choose X-ray as the initial diagnostic study. The only situation where stones appear on X-ray is when they contain enough calcium (pigment stones) or in the rare "porcelain gallbladder" (calcification of the gallbladder wall, which is associated with gallbladder carcinoma).
04Management and Treatment
Asymptomatic cholelithiasis
MANAGEMENT
Observation only
DETAILS
No surgical or medical intervention. Exceptions: porcelain gallbladder (cancer risk), gallstones > 3 cm, or patients undergoing bariatric surgery
Symptomatic biliary colic
MANAGEMENT
Elective laparoscopic cholecystectomy
DETAILS
Procedure of choice. Scheduled within weeks, not emergent
Acute pain management
MANAGEMENT
NSAIDs (ketorolac 30 mg IV or diclofenac 75 mg IM), antiemetics
DETAILS
NSAIDs are first-line for biliary colic pain. Opioids are second-line if needed
Non-surgical candidate (medical dissolution)
MANAGEMENT
Ursodeoxycholic acid (UDCA) 8-10 mg/kg/day orally, divided into 2-3 doses
DETAILS
Only for small (< 1 cm), radiolucent cholesterol stones in a functioning gallbladder. Treatment takes 6-12 months. High recurrence rate (50% within 5 years)
Extracorporeal shock wave lithotripsy (ESWL)
MANAGEMENT
Rarely used, adjunct to UDCA
DETAILS
For solitary cholesterol stone < 2 cm. Not widely recommended
CLINICAL SCENARIO | MANAGEMENT | DETAILS |
|---|---|---|
Asymptomatic cholelithiasis | Observation only | No surgical or medical intervention. Exceptions: porcelain gallbladder (cancer risk), gallstones > 3 cm, or patients undergoing bariatric surgery |
Symptomatic biliary colic | Elective laparoscopic cholecystectomy | Procedure of choice. Scheduled within weeks, not emergent |
Acute pain management | NSAIDs (ketorolac 30 mg IV or diclofenac 75 mg IM), antiemetics | NSAIDs are first-line for biliary colic pain. Opioids are second-line if needed |
Non-surgical candidate (medical dissolution) | Ursodeoxycholic acid (UDCA) 8-10 mg/kg/day orally, divided into 2-3 doses | Only for small (< 1 cm), radiolucent cholesterol stones in a functioning gallbladder. Treatment takes 6-12 months. High recurrence rate (50% within 5 years) |
Extracorporeal shock wave lithotripsy (ESWL) | Rarely used, adjunct to UDCA | For solitary cholesterol stone < 2 cm. Not widely recommended |
Asymptomatic gallstones do not require treatment. This is one of the most tested concepts. The majority of patients with gallstones (roughly 80%) will never develop symptoms. Prophylactic cholecystectomy is not indicated except in certain high-risk scenarios: a porcelain gallbladder (due to risk of gallbladder carcinoma), very large stones (> 3 cm, which also carry increased cancer risk), and patients with sickle cell disease where differentiating a sickle cell crisis from biliary colic may be difficult in the future.
For symptomatic biliary colic, the definitive treatment is elective laparoscopic cholecystectomy. "Elective" is the key word. Biliary colic is episodic and self-limited, so surgery is scheduled, not performed emergently. During an acute episode, pain is managed with NSAIDs (ketorolac 30 mg IV is commonly cited as first-line) because they reduce gallbladder prostaglandin-mediated contraction. Opioids can be used as second-line but carry a theoretical concern of sphincter of Oddi spasm (though clinically this is debated and should not prevent their use if needed). Dietary modification (low-fat diet) can reduce the frequency of episodes while awaiting surgery, but diet alone is not definitive therapy.
Ursodeoxycholic acid (UDCA) is the only medical dissolution therapy with proven efficacy. It works by reducing cholesterol saturation in bile. It is reserved exclusively for patients who are poor surgical candidates (high anesthetic risk) and who have small (< 1 cm), radiolucent, cholesterol stones in a functioning gallbladder (confirmed by HIDA scan showing cystic duct patency). The dose is 8-10 mg/kg/day divided into two or three doses, taken for 6-12 months. The recurrence rate after successful dissolution is high, approximately 50% within 5 years. UDCA does not work on pigment stones or calcified stones.
If a patient with biliary colic develops persistent pain lasting more than 6 hours, fever, or leukocytosis, the diagnosis has shifted to acute cholecystitis, and management changes to IV antibiotics plus urgent (not elective) cholecystectomy, ideally within 72 hours. Recognizing this transition is a commonly tested decision point.
05Differential Diagnosis and Distractors
Acute cholecystitis
WHY IT IS SIMILAR
Also presents with RUQ pain after meals; both involve gallstones
KEY DISCRIMINATOR
Cholecystitis has persistent pain > 6 hours, fever, leukocytosis, and a positive Murphy sign. Biliary colic resolves spontaneously with no systemic signs
Choledocholithiasis
WHY IT IS SIMILAR
RUQ pain with gallstones present
KEY DISCRIMINATOR
Elevated bilirubin and alkaline phosphatase, dilated common bile duct on ultrasound. In simple cholelithiasis, LFTs are normal
Ascending cholangitis
WHY IT IS SIMILAR
RUQ pain with jaundice
KEY DISCRIMINATOR
Charcot triad (fever, jaundice, RUQ pain) or Reynolds pentad (adds altered mental status and hypotension). Patient appears septic. Cholelithiasis patients are afebrile and non-toxic
Peptic ulcer disease (PUD)
WHY IT IS SIMILAR
Epigastric pain, nausea, may worsen with food
KEY DISCRIMINATOR
PUD pain is burning, often midline, may improve or worsen with food depending on location. No relation to fatty meals. Diagnosed by endoscopy, not ultrasound
Acute pancreatitis
WHY IT IS SIMILAR
Epigastric pain, nausea, vomiting, may be caused by gallstones
KEY DISCRIMINATOR
Pancreatitis pain radiates to the back, is persistent (not episodic), and lipase is elevated > 3x upper limit of normal. In simple cholelithiasis, lipase is normal
Gastroesophageal reflux disease (GERD)
WHY IT IS SIMILAR
Postprandial epigastric discomfort, nausea
KEY DISCRIMINATOR
GERD produces burning retrosternal pain, worsened by lying down. No RUQ tenderness. No ultrasound findings
Hepatitis
WHY IT IS SIMILAR
RUQ pain, nausea
KEY DISCRIMINATOR
Hepatitis shows markedly elevated transaminases (ALT > AST, often > 1000 in acute viral hepatitis). May have jaundice. Ultrasound shows no gallstones as the cause
Gallstone ileus
WHY IT IS SIMILAR
Involves gallstones
KEY DISCRIMINATOR
Presents with small bowel obstruction (nausea, vomiting, distension, obstipation). X-ray shows pneumobilia (air in biliary tree) and an ectopic stone in the small bowel. Very different clinical picture
DIFFERENTIAL | WHY IT IS SIMILAR | KEY DISCRIMINATOR |
|---|---|---|
Acute cholecystitis | Also presents with RUQ pain after meals; both involve gallstones | Cholecystitis has persistent pain > 6 hours, fever, leukocytosis, and a positive Murphy sign. Biliary colic resolves spontaneously with no systemic signs |
Choledocholithiasis | RUQ pain with gallstones present | Elevated bilirubin and alkaline phosphatase, dilated common bile duct on ultrasound. In simple cholelithiasis, LFTs are normal |
Ascending cholangitis | RUQ pain with jaundice | Charcot triad (fever, jaundice, RUQ pain) or Reynolds pentad (adds altered mental status and hypotension). Patient appears septic. Cholelithiasis patients are afebrile and non-toxic |
Peptic ulcer disease (PUD) | Epigastric pain, nausea, may worsen with food | PUD pain is burning, often midline, may improve or worsen with food depending on location. No relation to fatty meals. Diagnosed by endoscopy, not ultrasound |
Acute pancreatitis | Epigastric pain, nausea, vomiting, may be caused by gallstones | Pancreatitis pain radiates to the back, is persistent (not episodic), and lipase is elevated > 3x upper limit of normal. In simple cholelithiasis, lipase is normal |
Gastroesophageal reflux disease (GERD) | Postprandial epigastric discomfort, nausea | GERD produces burning retrosternal pain, worsened by lying down. No RUQ tenderness. No ultrasound findings |
Hepatitis | RUQ pain, nausea | Hepatitis shows markedly elevated transaminases (ALT > AST, often > 1000 in acute viral hepatitis). May have jaundice. Ultrasound shows no gallstones as the cause |
Gallstone ileus | Involves gallstones | Presents with small bowel obstruction (nausea, vomiting, distension, obstipation). X-ray shows pneumobilia (air in biliary tree) and an ectopic stone in the small bowel. Very different clinical picture |
06Traps and High-Yield Pearls
The single most common trap with cholelithiasis questions is confusing asymptomatic gallstones with symptomatic disease and recommending surgery when observation is the correct answer. If a vignette describes an incidental finding of gallstones on imaging done for another reason, with no history of biliary colic, the answer is reassurance and no intervention. Test-writers love to tempt you with cholecystectomy as an answer choice, banking on the assumption that "stones found = stones removed."
A second high-yield trap is the distinction between biliary colic and acute cholecystitis. Both involve gallstones and RUQ pain. The discriminator is duration and systemic signs: biliary colic resolves within 6 hours, has no fever, no leukocytosis, and a negative Murphy sign. If the vignette describes pain persisting beyond 6 hours with fever or a positive Murphy sign, the diagnosis is cholecystitis, and the management shifts from elective to urgent surgery. Read the timeline and vital signs carefully before choosing your answer.
Another tested concept involves the type of gallstone and its clinical context. When a vignette gives you a young patient with sickle cell disease or hereditary spherocytosis and gallstones, those are black pigment stones from chronic hemolysis. When a vignette describes a patient with biliary infection or parasites, think brown pigment stones. The default in an otherwise healthy patient with typical risk factors is cholesterol stones. The type of stone matters because UDCA only dissolves cholesterol stones.
Finally, remember that plain abdominal X-ray is never the best initial test for gallstones. Even though pigment stones are radiopaque, the majority of gallstones are not. Ultrasound is both the best initial and most accurate test for gallstones within the gallbladder. Do not confuse this with choledocholithiasis (stones in the common bile duct), where ultrasound sensitivity drops and MRCP or endoscopic ultrasound becomes the preferred study. The core competency being tested in cholelithiasis questions is your ability to match the clinical scenario (asymptomatic vs. symptomatic vs. complicated) to the correct management pathway and to avoid overtreating an incidental finding.